You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 23, 2024

Fludeoxyglucose f-18 - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for fludeoxyglucose f-18 and what is the scope of freedom to operate?

Fludeoxyglucose f-18 is the generic ingredient in one branded drug marketed by Downstate Clincl, 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens, Cardinal Health 414, Childrens Hosp Mi, Decatur, Essential Isotopes, Feinstein, Hot Shots Nm Llc, Isologic Innovative, Jubilant Draximage, Kettering Medctr, Kreitchman Pet Ctr, Ma General Hosp, Mcprf, Mem Sloan-kettering, Methodist Hosp Res, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Northland, Nukemed, Petnet, Pharmalogic, Pharmalogic Hldgs, Precision Nuclear, Queen Hamamatsu Pet, Sofie, Trustees Univ Pa, Ucla Biomedical, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Michigan, Univ Southern Ca, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Utah Cyclotron, Weill Medcl Coll, Wisconsin, and Wusm Cyclotron, and is included in forty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for fludeoxyglucose f-18. Twenty-seven suppliers are listed for this compound.

Summary for fludeoxyglucose f-18
US Patents:0
Tradenames:1
Applicants:41
NDAs:43
Drug Master File Entries: 3
Finished Product Suppliers / Packagers: 27
Raw Ingredient (Bulk) Api Vendors: 20
Clinical Trials: 181
Patent Applications: 1,672
What excipients (inactive ingredients) are in fludeoxyglucose f-18?fludeoxyglucose f-18 excipients list
DailyMed Link:fludeoxyglucose f-18 at DailyMed
Recent Clinical Trials for fludeoxyglucose f-18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Robert Flavell, MD, PhDPhase 1
Michael TopfPhase 1
Xencor, Inc.Phase 1

See all fludeoxyglucose f-18 clinical trials

Pharmacology for fludeoxyglucose f-18

US Patents and Regulatory Information for fludeoxyglucose f-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cardinal Health 414 FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203603-001 Nov 13, 2015 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Essential Isotopes FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203946-001 Feb 5, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Petnet FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 079086-001 Feb 25, 2011 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.